Evidence map›Paper›PMID 20175991›Full record

ArticleBiochemical and biophysical research communications2010

Inactivation of NEIL2 DNA glycosylase by pyridoxal phosphate reveals a loop important for substrate binding.

Inga R Grin, Robert A Rieger, Dmitry O Zharkov

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. A Low-Activity Polymorphic Variant of Human NEIL2 DNA Glycosylase.International journal of molecular sciences · 2022
    Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Inga R GrinSB RAS Institute of Chemical Biology and Fundamental Medicine, 8 Lavrentieva Ave, Novosibirsk 630090, Russia.
Robert A Rieger
Dmitry O Zharkov
Siberian Branch of the Russian Academy of Sciences · RUStony Brook University · US

Funding

POTENTIAL ANTIVIRAL AGENTS--TRIPHENYLMETHANE DYESR01CA017395 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI GROLLMAN, ARTHUR PATRICK · 1985 to 2012
$4.1M
NCI NIH HHS R01 CA017395
6 · The paper itself

Abstract

Pyridoxal-5'-phosphate (PLP), in addition to its known metabolic functions, inactivates many DNA-dependent enzymes through conjugation to their critical amino groups. We have investigated the ability of PLP to inhibit bifunctional DNA repair glycosylases, which possess a catalytic amine. Of six enzymes tested, only endonuclease VIII-like protein 2 (NEIL2) was significantly inhibited by PLP. The inhibition was due to Schiff base formation between PLP and the enzyme. PLP-conjugated NEIL2 completely lost its ability to bind damaged DNA. Liquid chromatography/nanoelectrospray ionization tandem mass spectrometry of the products of proteolysis of pyridoxylated NEIL2 identified Lys50 as the site of modification. Thus, the beta2/beta3 loop where Lys50 is located in NEIL2 is important for DNA binding, presumably lies next to a phosphate-binding site, and may represent a target for regulation of the enzyme activity.

Indexed as

Amino Acid SequenceAnimalsDNA-(Apurinic or Apyrimidinic Site) LyaseDNA GlycosylasesHumansMiceMolecular Sequence DataProtein Structure, SecondaryPyridoxal PhosphateSchiff BasesSpectrometry, Mass, Electrospray IonizationSubstrate SpecificityTandem Mass SpectrometryDNA-(Apurinic or Apyrimidinic Site) LyaseDNA GlycosylasesNEIL2 protein, humanNeil2 protein, mousePyridoxal PhosphateSchiff Bases

Identifiers

PMID20175991
PMCPMC2857644
OpenAlexW2083070060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.